Physician profile
Eric William Shreve
NPI 1821123316
$7,674.87
in general payments reported to CMS, 2019-2025
24 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $959 · 2021: $972 · 2022: $2,773 · 2023: $998 · 2024: $931 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,156.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,809.05 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $2,158.82 | 2020-2024 | Axonics |
| Neotract INC. | $550.93 | 2019-2020 | |
| Coloplast Corp | $473.78 | 2019-2024 | |
| Astellas Pharma US INC | $261.48 | 2019-2022 | |
| Boston Scientific Corporation | $213.90 | 2019-2025 | Ams 700, Axonics |
| Myovant Sciences INC. | $173.72 | 2021-2022 | |
| Janssen Biotech, INC. | $166.12 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $146.61 | 2019-2025 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $123.97 | 2024 | |
| Palette Life Sciences, INC. | $112.74 | 2021-2022 | |
| Immunitybio, INC. | $105.18 | 2024 | |
| Myriad Genetic Laboratories, INC. | $83.00 | 2022 | |
| Abbvie INC. | $65.00 | 2019-2024 | |
| Procept Biorobotics Corporation | $39.45 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $37.55 | 2021-2025 | |
| Rochester Medical Corporation | $33.94 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $24.17 | 2019 | |
| Calyxo, INC. | $22.73 | 2024 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $18.27 | 2020 | |
| Conmed Corporation | $15.30 | 2021 | |
| Endo Pharmaceuticals INC. | $14.83 | 2019 | |
| Sagent Pharmaceuticals | $12.34 | 2021 | |
| Pfizer INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shreve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.